H Donald Burns

Title: H Donald Burns: Innovator in Radiolabeled Compounds

Introduction

H Donald Burns is a notable inventor based in Harleysville, PA (US). He has made significant contributions to the field of radiolabeled compounds, holding a total of 7 patents. His work primarily focuses on the development of innovative diagnostic imaging techniques.

Latest Patents

Among his latest patents are the "Radiolabeled glycine transporter inhibitors," which are designed for the labeling and diagnostic imaging of glycine transporters in mammals. Another significant patent is for "Radiolabeled cannabinoid-1 receptor modulators," which relates to specific radiolabeled Cannabinoid-1 (CB1) receptor modulators. This invention includes methods for using these modulators for labeling and diagnostic imaging of Cannabinoid-1 receptors in mammals, particularly humans. Additionally, it discloses intermediates useful for synthesizing these radiolabeled compounds and the processes involved in their synthesis.

Career Highlights

H Donald Burns has worked with prominent companies in the pharmaceutical industry, including Merck & Company, Inc. and Merck Sharp & Dohme Corporation. His experience in these organizations has contributed to his expertise in the development of innovative medical imaging technologies.

Collaborations

Throughout his career, H Donald Burns has collaborated with notable colleagues such as Terence G Hamill and Raymond E Gibson. These partnerships have likely enhanced his research and development efforts in the field of radiolabeled compounds.

Conclusion

H Donald Burns is a distinguished inventor whose work in radiolabeled compounds has advanced diagnostic imaging techniques. His contributions continue to impact the medical field positively.